Entering text into the input field will update the search result below

Celgene (CELG +2.8%) gains on an upgrade to Buy on valuation at Argus, citing the company's...

Jun. 29, 2012 2:07 PM ETCelgene Corporation (CELG) StockCELGBy: David Yelle, SA News Editor
Celgene (CELG +2.8%) gains on an upgrade to Buy on valuation at Argus, citing the company's reiterated guidance following the Revlimid setback.

Recommended For You

More Trending News

Related Stocks

SymbolLast Price% Chg
CELG--
Celgene Corporation